Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

Chromocell Therapeutics (CHRO)

Chromocell Therapeutics Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:AMEX:CHRO
DateTimeSourceHeadlineSymbolCompany
15/05/202421:15Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]AMEX:CHROChromocell Therapeutics Corporation
15/05/202421:06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:CHROChromocell Therapeutics Corporation
13/05/202414:00GlobeNewswire Inc.Chromocell To Present at Alliance Global Partner’s Healthcare Company Showcase on Tuesday, May 21, 2024AMEX:CHROChromocell Therapeutics Corporation
09/04/202413:30GlobeNewswire Inc.Chromocell Issues Letter to Stockholders from Chief Executive OfficerAMEX:CHROChromocell Therapeutics Corporation
21/03/202412:30GlobeNewswire Inc.Chromocell Announces Formal Launch of Eye Pain Treatment Program and Hiring of Dr. Simon ChandlerAMEX:CHROChromocell Therapeutics Corporation
18/03/202414:00GlobeNewswire Inc.Chromocell Names Frank Knuettel as Chief Executive Officer, Removing Interim Status Held Since July 2023AMEX:CHROChromocell Therapeutics Corporation
11/03/202413:00GlobeNewswire Inc.Chromocell to Present at Sidoti Virtual Investor Conference March 13-14AMEX:CHROChromocell Therapeutics Corporation
27/02/202413:00GlobeNewswire Inc.Benuvia Operations, LLC and Chromocell Therapeutics Corp. Announce Strategic Partnership to Advance Healthcare SolutionsAMEX:CHROChromocell Therapeutics Corporation
21/02/202421:47GlobeNewswire Inc.Chromocell Therapeutics Announces Closing of Initial Public Offering for Gross Proceeds of $6.6 MillionAMEX:CHROChromocell Therapeutics Corporation
16/02/202413:00GlobeNewswire Inc.Chromocell Therapeutics Announces Pricing of Upsized $6.6 Initial Public OfferingAMEX:CHROChromocell Therapeutics Corporation
 Showing the most relevant articles for your search:AMEX:CHRO